What is Definium Therapeutics Inc (DFTX)?
Definium Therapeutics Inc is a biotechnology company engaged in the development of targeted cancer therapies. Its research focuses on creating treatments that harness the immune system to selectively attack cancer cells while minimizing effects on healthy tissue. The company utilizes proprietary technologies to design antibody-based therapies and other biologics aimed at improving efficacy and safety profiles. Definium Therapeutics operates within the pharmaceutical and biotechnology sectors, emphasizing innovation in oncology drug development. Its pipeline includes various candidates at different stages of research and development, reflecting ongoing efforts to address unmet medical needs in cancer treatment.
Definium Therapeutics Inc Stock Price Today: Live Overview
The price today is shaped by live trading trends, with Definium Therapeutics Inc priced at $18.15. The instrument’s intraday range spans from $17.99 to $18.64, accompanied by a daily percentage shift of -1.2068%.
FAQ: Definium Therapeutics Inc (DFTX)
What is the current price of DFTX stock?
The current trading price is $18.15.
Does DFTX pay dividends?
Definium Therapeutics Inc does not pay dividends.
Does DFTX have a formal corporate presence or regional headquarters in the UAE?
Definium Therapeutics Inc operates in the UAE only via partners and distributors without an official office or subsidiary.
What is DFTX best known for?
Definium Therapeutics Inc is most famous for its work in developing targeted cancer therapies.
What assets are typically shown together with DFTX?
Commonly shown alongside DFTX: Cassava Sciences Inc, Bolt Biotherapeutics, Inc., Intuitive Machines Inc
Latest shares articles



